St. Louis

Three Men Plead Guilty to Steroid Distribution Conspiracy in Federal Court

AI Assisted Icon
Published on December 06, 2024
Three Men Plead Guilty to Steroid Distribution Conspiracy in Federal CourtSource: Google Street View

Three men have recently entered guilty pleas in a federal court, acknowledging their roles in a scheme involving the distribution of thousands of anabolic steroids. According to details released by the U.S. Attorney's Office, 44-year-old David Underwood, 39-year-old Andrew Moore, and 33-year-old Jeffrey Swanson have admitted to conspiracy charges related to the sale of these controlled substances.

Documents from the plea agreements reveal that the operations began with Swanson distributing anabolic steroids on Facebook back in November 2018. By mid-2019, Moore and Swanson had launched a new venture under the guise of a Facebook page called "SP Online" or "SP Pharma." The duo reportedly obtained raw steroids which they then processed and packaged, selling them directly to customers who selected from a "menu" posted on the Facebook page, paying by mail with cash. Underwood joined the operation around May 2020, establishing a page known as "LLL Online," continuing the sale of steroids in the shadow of the so-called "Lay Low Labs."

An undercover officer engaged in purchases of steroids from Moore, during which, Moore divulged that he bought approximately one kilogram of the raw product per transaction. Swanson and Underwood separately continued their sales, expanding their reach within the digital shadows of social media. The investigation into these activities unlocked thousands of orders and a staggering number of units attributed to the illicit sales.

In the courtroom, Swanson assumed responsibility for the distribution of more than 60,000 units. Underwood admitted to a range between 20,000 and 40,000, and, Moore for 40,000 to 60,000 units. The extensive probe, led by the combined forces of the Drug Enforcement Administration, the U.S. Postal Inspection Service, the U.S. Food and Drug Administration, and the Internal Revenue Service Criminal Investigations, concluded with Assistant U.S. Attorney Stephen Casey spearheading the prosecution.